vimarsana.com

DocGo (NASDAQ:DCGO – Get Free Report) had its target price decreased by equities research analysts at Canaccord Genuity Group from $10.00 to $9.00 in a research note issued on Thursday, Benzinga reports. The firm presently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective would indicate a potential upside of 168.66% from […]

Related Keywords

United Kingdom ,United States ,Michaelj Burdiek ,Stifel Nicolaus ,Deerfield Management Companylp Series ,Docgo Company Profile ,Securities Exchange Commission ,Northern Trust Corp ,Needham Company ,Docgo Inc ,Cantor Fitzgerald ,Sectoral Asset Management Inc ,Canaccord Genuity Group ,Investment Management ,Get Free Report ,Genuity Group ,Director Michael ,Exchange Commission ,Street Corp ,Asset Management ,Trust Corp ,Docgo Daily ,Docgo ,Nasdaq Dcgo ,Dcgo ,Medical ,Lower Price Target ,Canaccord Genuity Group Inc ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.